# OncoSec Medical Incorporated (ONCS)

Source: https://www.quantisnow.com/company/ONCS
Generated: 2026-11-08T05:30:26.449Z

- Ticker: ONCS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Website: oncosec.com

## About

OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 (IL-12) for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in Phase IIb clinical trials (KEYNOTE-695) and advanced or metastatic triple negative breast cancer (TNBC), which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and new DNA-encoded therapeutic candidates and tumor indications to treat deep visceral lesions, such as liver, lung, bladder, pancreatic, and other visceral lesions. It has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate enhanced IL-12 DNA-plasmid; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was founded in 2008 and is headquartered in Pennington, New Jersey.

## Latest ONCS news and filings

- 2024-02-13 19:30 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by OncoSec Medical Incorporated (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-oncosec-medical-incorporated-amendment-5254031)
- 2023-07-10 10:08 UTC [SEC Form 25-NSE filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-oncosec-medical-incorporated-4733558)
- 2023-06-23 17:37 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-4678089)
- 2023-06-23 16:20 UTC [Market Insight] [Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session](https://www.quantisnow.com/insight/why-carmax-shares-are-trading-lower-by-10-here-are-4677781)
- 2023-06-23 13:12 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-4676419)
- 2023-06-23 12:14 UTC [Market Insight] [Why Virgin Galactic Are Trading Lower By Around 18%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-virgin-galactic-are-trading-lower-by-around-18-here-4676090)
- 2023-06-22 12:30 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-notice-of-delisting-4670907)
- 2023-06-15 18:53 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Thursday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-thursday-4647602)
- 2023-06-15 18:52 UTC [Market Insight] [Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results](https://www.quantisnow.com/insight/crude-oil-rises-sharply-jabil-posts-upbeat-q3-results-4647600)
- 2023-06-15 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-4647254)
- 2023-06-15 17:12 UTC [Market Insight] [Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-john-wiley-sons-shares-are-trading-lower-by-around-4647176)
- 2023-06-15 16:06 UTC [Market Insight] [Dow Surges Over 300 Points; Kroger Profit Beats Views](https://www.quantisnow.com/insight/dow-surges-over-300-points-kroger-profit-beats-views-4646806)
- 2023-06-15 13:07 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-4645550)
- 2023-06-15 12:05 UTC [Market Insight] [Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-microvision-shares-are-trading-higher-by-28-here-are-4644844)
- 2023-06-15 10:48 UTC [Market Chatter] [OncoSec Medical shares are trading lower after the company filed a voluntary petition for relief under bankruptcy, CEO resignation](https://www.quantisnow.com/insight/oncosec-medical-shares-are-trading-lower-after-the-company-filed-4644233)
- 2023-06-14 21:28 UTC [Market Chatter] [OncoSec Medical Files Voluntary Petition For Relief Under Bankruptcy](https://www.quantisnow.com/insight/oncosec-medical-files-voluntary-petition-for-relief-under-bankruptcy-4643152)
- 2023-06-14 21:24 UTC [Market Insight] [Oncosec Medical Announced Robert Arch Tendered His Resignation As Company's President And CEO Effective On June 14; Co WIll Have No Remaining Executive Officers](https://www.quantisnow.com/insight/oncosec-medical-announced-robert-arch-tendered-his-resignation-as-companys-4643117)
- 2023-06-14 21:20 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-bankruptcy-or-receivership-4643090)
- 2023-06-14 21:00 UTC [Market Chatter] [OncoSec Medical Says On June 12, 2023, George Chi Was Terminated For Cause As An Employee And CFO](https://www.quantisnow.com/insight/oncosec-medical-says-on-june-12-2023-george-chi-was-4642824)
- 2023-06-14 20:55 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-leadership-update-4642778)
- 2023-06-02 21:00 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-notice-of-delisting-4597955)
- 2023-05-26 20:38 UTC [SEC Form D] [SEC Form D filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-d-filed-by-oncosec-medical-incorporated-4568937)
- 2023-05-25 20:13 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-oncosec-medical-incorporated-4561080)
- 2023-05-19 18:57 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-oncosec-medical-incorporated-4533026)
- 2023-05-18 20:35 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-entry-into-a-4528538)
- 2023-05-18 20:30 UTC [Public Offering] [OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/oncosec-announces-closing-of-133-million-registered-direct-offering-priced-4528410)
- 2023-05-18 13:30 UTC [SEC Form 424B5] [SEC Form 424B5 filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-oncosec-medical-incorporated-4525477)
- 2023-05-16 18:50 UTC [Market Chatter] [OncoSec shares are trading lower after the company announced a $1.33 million registered direct offering priced at-the-market under Nasdaq rules.](https://www.quantisnow.com/insight/oncosec-shares-are-trading-lower-after-the-company-announced-a-4514162)
- 2023-05-16 17:52 UTC [Market Insight] [OncoSec Announces $1.33M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/oncosec-announces-133m-registered-direct-offering-priced-at-the-market-under-nasdaq-4513908)
- 2023-05-16 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-4513843)
- 2023-05-16 17:29 UTC [Public Offering] [OncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/oncosec-announces-133-million-registered-direct-offering-priced-at-the-market-under-4513830)
- 2023-05-16 17:13 UTC [Market Insight] [Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-rh-shares-are-trading-lower-by-8-here-are-4513752)
- 2023-05-16 12:15 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-other-events-financial-4511144)
- 2023-05-16 12:08 UTC [Market Chatter] [OncoSec Announces Type C Meeting With FDA Was Held On May 15](https://www.quantisnow.com/insight/oncosec-announces-type-c-meeting-with-fda-was-held-on-4511076)
- 2023-05-16 12:00 UTC [OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program](https://www.quantisnow.com/insight/oncosec-is-encouraged-after-fda-meeting-to-discuss-proposed-neoadjuvant-4510885)
- 2023-04-27 12:00 UTC [SEC Form 8-K] [OncoSec Medical Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/oncosec-medical-incorporated-filed-sec-form-8-k-other-events-financial-4394428)
- 2023-04-27 11:38 UTC [Market Chatter] [OncoSec Medical Reports Receipt Of $3.49M In Tax Credit Certificates From The New Jersey Economic Development Authority](https://www.quantisnow.com/insight/oncosec-medical-reports-receipt-of-349m-in-tax-credit-certificates-4394143)
- 2023-04-27 11:30 UTC [OncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL Program](https://www.quantisnow.com/insight/oncosec-receives-349-million-to-strengthen-its-balance-sheet-after-4394065)
- 2023-04-24 21:05 UTC [SEC Form D] [SEC Form D filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-d-filed-by-oncosec-medical-incorporated-4375503)
- 2023-04-17 20:01 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by OncoSec Medical Incorporated](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-oncosec-medical-incorporated-4343986)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ONCS
- Earnings history: https://www.quantisnow.com/earnings/ONCS
- Dividend history: https://www.quantisnow.com/dividends/ONCS
- Insider transactions: https://www.quantisnow.com/insiders/ONCS
- Options chain: https://www.quantisnow.com/options/ONCS
- SEC 8-K filings only: https://www.quantisnow.com/company/ONCS/8-k
- RSS and alerts for ONCS: https://www.quantisnow.com/docs/rss-feeds.md